Home · Health · Sep 14 archive
Abbott Agrees to $385 Million Settlement Over Sturgis Formula Plant Closure
Confirmed
In Short: Abbott Laboratories has agreed to a $385 million settlement related to the closure of its Sturgis, Michigan, facility, which was under investigation for contamination.
No unopened, distributed Abbott infant formulas have ever tested positive for Cronobacter sakazakii, according to the company.
The Sturgis facility, the largest in the U.S., was closed in February 2022 after the Food and Drug Administration began an investigation.
The recall covered several infant formula brands, including Similac, and squeezed inventory that had already been strained by supply chain disruptions and stockpiling during the COVID-19 shutdowns.
The settlement pertains to lawsuits filed by the Justice Department and certain relators, as well as the Attorneys General of several states, though Abbott stated the resolution contains no finding of fault or liability.
The Biden administration eased import rules for foreign manufacturers, airlifted formula from Europe, and invoked federal emergency rules to prioritize U.S. supply.
The Justice Department under President Donald Trump closed its criminal investigation into the matter, and the settlement covers litigation initiated by specific relators as well as the Attorneys General of multiple states.
What's confirmed
- Abbott said on Monday that tests by government regulators of unopened product from the homes of the infants under investigation at the time of the 2022 recall were negative for Cronobacter sakazakii, a bacterium that can cause illness in infants.
- The company also said that no unopened, distributed Abbott infant formulas have ever tested positive for Cronobacter sakazakii.
- Abbott closed the Sturgis facility in February 2022 after the Food and Drug Administration began an investigation.
- Abbott Laboratories will pay $385 million to resolve claims tied to an investigation of contamination at a baby formula factory in Sturgis, Michigan, the largest in the country, which led to the supply shortages in 2022.
- Problems at the facility prompted a lawsuit by the Justice Department and recall of powdered infant formula at the facility.
- The recall covered several infant formula brands, including Similac, and squeezed inventory that had already been strained by supply chain disruptions and stockpiling during COVID-19 shutdowns.
- The settlement, which Abbott says does not represent any finding of fault or liability, also pertains to lawsuits filed by certain relators and the Attorneys General of several states.
- The Biden administration eased import rules for foreign manufacturers, airlifted formula from Europe and invoked federal emergency rules to prioritize U.S.
What's still developing
- You may opt out of receiving STAT communications at any time.
- Greg Abbott's decision to block funding for Flock surveillance cameras and discuss former Attorney General Ken Paxton's appearance in a video game.
- They also cover Meta's $1 billion settlement with Texas and what it could mean for the state's ongoing battles with the tech giant.